PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification

New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics WALTHAM, Mass. –(BUSINESS WIRE)–Apr. 4, 2022– PerkinElmer, Inc. ,   a global leader committed to innovating for a healthier world, today announced two